Stimulant Use Clinical Trial
Official title:
Financial Incentives to Promote Stimulant Abstinence in a Community-Based Syringe Exchange Program
The goal of this randomized control pilot study is to learn about a financial incentives intervention among individuals who use stimulants and take part in a community-based syringe exchange program. The main question it aims to answer is how financial incentives for not using stimulants will impact stimulant use. Participants in the experimental group will have the opportunity to earn financial incentives for providing a negative urine sample for stimulants using a point-of-care test, which indicates abstinence from stimulant use, along with health education on the health risks of stimulant use and substance injection. Researchers will compare the experimental group to the control group who will receive health education on the health risks of stimulants use and injection.
The investigators are proposing a two condition, parallel groups, randomized control pilot study to evaluate the efficacy of a financial incentives intervention among individuals who use stimulants and take part in a community-based syringe exchange program. The study design will include recruiting service recipients who already participate in programs offered by a syringe exchange program.The experimental group will have the opportunity to earn financial incentives contingent on providing a negative urine sample for stimulants using a point-of-care test, which indicates abstinence from stimulant use, in addition to health education on the health risks of stimulant use and substance injection. The control group will receive health education on the health risks of stimulants use and injection. All participants will participate in their syringe exchange services as usual. The investigators chose the health education as the control because participants across both conditions already receive the services provided by the syringe exchange program. Moreover, this control condition will help control for a potential type of between-groups variability. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04061941 -
Change in Cognitive Function in Stimulant Users
|
||
| Not yet recruiting |
NCT05097547 -
Contingency Management for Stimulant Use Disorders
|
N/A | |
| Recruiting |
NCT06073340 -
The Longitudinal Study of Stimulant Use Disorder
|
||
| Recruiting |
NCT04642820 -
Drugs Brain and Behavior (DDP)
|
Early Phase 1 | |
| Completed |
NCT05379959 -
Effects of Stimulants on Behavioral and Neural Markers of Social Motivation, Ability, and Neural Markers of Social Function
|
Early Phase 1 | |
| Recruiting |
NCT05835921 -
Enhancing Prospective Thinking in Early Recovery
|
N/A | |
| Recruiting |
NCT05140876 -
Supporting Treatment Adherence for Resilience and Thriving (START)
|
N/A | |
| Withdrawn |
NCT04553263 -
Relapse Prevention in Stimulant Use Disorder
|
Early Phase 1 | |
| Recruiting |
NCT04426214 -
Neuromodulation and Cognitive Training for Substance Use Disorders
|
N/A | |
| Recruiting |
NCT04899024 -
PrEP Affect Regulation Treatment Innovation
|
N/A | |
| Recruiting |
NCT03470480 -
rTMS for Craving in Methamphetamine Use Disorder
|
N/A | |
| Active, not recruiting |
NCT04907357 -
rTMS for Stimulant Use Disorders
|
N/A | |
| Recruiting |
NCT03935646 -
Acute Effects of Stimulant Medication in College Students With ADHD
|
Phase 2 |